FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Fusion Microfinance earned an interest income of Rs 360.45 crore for Q1FY23 and posted a PAT of Rs 75.10 crore for the same period. The Issuer's interest income rose by 29% to Rs 1064.32 crore for FY22 against Rs 827.56 crore for FY21. However, PAT has reduced to Rs 21.76 crore for FY22 from Rs 43.94 crore in FY21. The decrease was due to higher finance costs and operating costs during the year.
Particulars | Q1FY2023 | Q1FY2022 | FY2022 | FY2021 | FY2020 |
Total Revenue | 360.45 | 264.96 | 1201.35 | 873.09 | 730.31 |
Interest Income | 329.36 | 249.97 | 1064.32 | 827.56 | 666.49 |
PAT | 75.1 | 4.41 | 21.76 | 43.94 | 69.61 |
EBITDA | 224.79 | 129.86 | 525.76 | 495.79 | 440.24 |
Total Assets | 7615.24 | 5824.87 | 7290.48 | 5837.93 | 4239.99 |
Fusion MFI has a higher debt-equity ratio of 4.24 (Q1FY23), 4.32 (FY22), 3.56 (FY21), and 2.48 (FY20). The total borrowings were Rs 6182 crore as on 30th June 2022. In this nature of business, MFI/NBFCs have to raise funds through a mix of debt and equity and thus their debt and finance costs are on the higher side. For Fusion MFI also, debt and finance costs show an increasing trend.
The IPO is valued at 10.14 times with annualized EPS of 36.28 for Q1FY23 calculated at the upper price band of Rs 368. However with EPS of 2.67 for FY22, P/E is 137.83x as compared to industry average of 114.50x which indicates that the IPO is valued at a higher side. For listed peer related data and information, refer the Peer table comparison given below.
Particulars | Credit Access Grameen | Spandan Sphoorty | Bandhan Bank | Ujjivan | Equitas | Suryoday | Fusion |
Face Value/share | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Total Income for FY22 (Cr) | 2750.13 | 1480.04 | 16693.9 | 3126.1 | 3997.2 | 1035.4 | 1201.4 |
EPS (FY22) | 23.31 | 10.75 | 0.78 | -2.4 | 2.43 | -8.76 | 2.67 |
NAV per share | 225.19 | 447.21 | 107.91 | 16.22 | 33.91 | 141.78 | 161.7 |
Return on net worth | 8.98% | 2.26% | 0.72% | -14.91% | 6.61% | -6.98% | 1.63% |
P/E | 42.6 | 52.76 | 342.44 | NA | 20.21 | NA | NA |
Gross NPA(FY22) | 3.60% | 15% | 6.50% | 7.10% | 4.10% | 11.80% | 5.70% |
Current market price | 953.1 | 599.2 | 265.35 | 25 | 49 | 99.2 | NA |
IPO price | 422 | 856 | 375 | 37 | 33 | 305 | 368 |
Listing price | 385 | 825 | 487 | 58.75 | 31 | 292 | NA |
Listing Year | Aug-2018 | Aug-2019 | Mar-2018 | Dec-2019 | Nov-2020 | Mar-2021 | NA |
FusionIPO opens on 2nd Nov- 4th Nov 2022 with a price band of 350-368 per share. The retail quota is 35% and investors can apply with a minimum bid of 40 shares (Rs 14,720). The maximum lot size is 520 shares (Rs 1,91,360). The issue is both a fresh issue and an offer for sale by promoter group, Oikocredit, and Global Impact Funds. The issue is expected to list on 15th Nov 2022.
The Issuer has been one of the youngest companies in terms of getting an NBFC-MFI license and among the top NBFC-MFIs in India in terms of AUM as of June 30, 2022. The Issuer had the fourth fastest gross loan portfolio CAGR of 53.89% between FY 2017 and FY 2021 among the 10 largest NBFC-MFIs in India.
However, If we analyze the listing of NBFCs as shown above, one can see that NBFCs listed in the last couple of years have not been able to give good returns to investors. This is mainly due to the challenges faced by the sector such as raising sufficient funds, high credit costs, compliance issues, and high operating costs.
In addition to the above, the Issue appears to be overvalued and hence one can avoid this IPO.
Review By CA Priyanka Choudhary on 27th Oct 2022
About CA Priyanka Choudhary
Priyanka Choudhary Jain is a Chartered Accountant and an experienced credit analyst. She has worked with CRISIL as Senior Credit Analyst on ratings assignments including business and financial analysis in Corporates as well as the Public Finance Sector.
Email: [email protected]
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published here. Any reader taking decisions based on any information published here does so entirely at own risk. Investors should bear in mind that any investment in stock markets are subject to unpredictable market related risks. Above information is based on RHP and other documents available as of date coupled with market perception. Author has no plans to invest in this offer.